- Home
- AIRI vs MDCX Comparison
AIRI vs MDCX Comparison
Compare AIRI & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AIRI | MDCX |
|---|---|---|
| Founded | 1979 | 2008 |
| Country | United States | United States |
| Employees | N/A | 12 |
| Industry | Military/Government/Technical | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 13.7M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRI | MDCX |
|---|---|---|
| Price | $3.21 | $0.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 66.2K | ★ 8.4M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 24.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,921,000.00 | N/A |
| Revenue This Year | $6.43 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.55 | $0.37 |
| 52 Week High | $4.17 | $8.90 |
Technical Indicators
Market Signals| Indicator | AIRI | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 34.89 |
| Support Level | $3.18 | $0.37 |
| Resistance Level | $3.38 | $1.70 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 68.29 | 36.57 |
Price Performance
Historical ComparisonAbout AIRI Air Industries Group
Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.